Leading Tech M&A Advisor in Europe With more than 100 deals closed in 8 years, Avolta Partners has proven to be one of the most active M&A advisors in Europe in the Tech Industry. For more information, visit www.avoltapartners.com Venture Capital, Fundraising, M&A, Corporate Finance, and Tech

Sectors: Finance

Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and …

Sectors: French Cluster Public business cluster

[Automatic translation follows] 1st startup association in Europe, with +2,000 French digital startup and investor members Founded in 2012, France Digitale is the largest startup association in Europe, with more than 2,000 French digital startup and investor members. Our missions? - Create digital champions in Europe. - Speak up and unite those who innovate to change the face of the world. - Create bridges and business opportunities between all innovation stakeholders, whether large groups, public decision-makers, investors, entrepreneurs or employees of startups and scale-ups. How ? 1. By connecting ecosystem players during quality meetings, business meetings or even institutional hearings. …

Sectors: Startup accelerator & VC

We are dedicated to therapeutic progress to serve patient needs. Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and …

Sectors: Pharmaceutical